A carregar...

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer

Although platinum-based chemotherapy remains the “standard” in advanced non small-cell lung cancer, not all patients derive clinical benefit from such a treatment. Hence, the development of predictive biomarkers able to identify lung cancer patients who are most likely to benefit from cisplatin-base...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mountzios, Giannis, Dimopoulos, Meletios-Athanasios, Papadimitriou, Christos
Formato: Artigo
Idioma:Inglês
Publicado em: Libertas Academica 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2688360/
https://ncbi.nlm.nih.gov/pubmed/19578506
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!